RENBIOLOGICS
Dead / Abandoned — Abandoned — failure to respond (as of 24 Feb 2025)
What this means for you
This application is over — abandoned 10 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79395221
- Mark type
- Stylized text
- Filed
- 27 Dec 2023
- Abandoned
- 10 Feb 2025
Goods and services
- Class 001 — Chemicals: Protein [raw material]; radioactive elements for scientific purposes; preparations of trace elements for plants; biochemical preparations for scientific purposes; biological preparations, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purpose; bacteriological preparations other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; proteins for the food industry.
- Class 005 — Pharmaceuticals: Medicines for human purposes; biological preparations for medical purposes; preparations of microorganisms for medical or veterinary use; biological tissue cultures for medical purposes; colostral antibodies for medical purposes; vaccines; living cells for medical purposes; biochemical medicines; pharmaceutical preparations; pharmaceutical substances; medical preparations for treating diseases and disorders related to the immune system; pharmaceutical preparations for the prevention and treatment of cancer; diagnostic preparations for medical purposes; dietetic substances adapted for medical use; medicines for veterinary purposes.
- Class 042 — Scientific and technological services: Technological research; biochemical research and analysis; drug development; pharmaceutical product evaluation; clinical trials; research and development services in the field of antibodies; biological research; research in the field of gene editing technology; research in the field of cell engineering technology; culturing of cells for scientific research purposes; development of pharmaceutical preparations and pharmaceuticals; biomedical research.
Owner
Prosecution history
- 12 Mar 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Feb 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Feb 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 24 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 08 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 24 Feb 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 24 Feb 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 01 Sept 2024 — REFUSAL PROCESSED BY IB
- 09 Aug 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 09 Aug 2024 — REFUSAL PROCESSED BY MPU
- 27 Jul 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 26 Jul 2024 — NON-FINAL ACTION WRITTEN
- 25 Jul 2024 — ASSIGNED TO EXAMINER
- 15 May 2024 — APPLICATION FILING RECEIPT MAILED